Editorial to the “safety and efficacy of direct oral anticoagulants compared to vitamin K antagonist post percutaneous coronary artery interventions in patients with atrial fibrillation: A systematic revie and meta‐analysis”

Atrial fibrillation (AF) and coronary artery disease (CAD) sometimes coexist in clinical practice, and the prevalence of CAD in AF patients and AF in percutaneous coronary artery intervention (PCI) patients has been reported to be around 8%–15% in Japan. According to the AHA expert consensus (A Nort...

Full description

Saved in:
Bibliographic Details
Published in:Journal of arrhythmia 2020-04, Vol.36 (2), p.280-281
Main Authors: Okumura, Yasuo, Nagashima, Koichi
Format: Article
Language:English
Subjects:
Acute coronary syndromes
Anticoagulants
Anticoagulants (Medicine)
Atrial fibrillation
Cardiac arrhythmia
Cardiac patients
Cardiovascular disease
Care and treatment
Clinical medicine
Clopidogrel
Comparative analysis
Coronary heart disease
Coronary vessels
direct oral anticoagulants
Drug therapy, Combination
dual therapy
percutaneous coronary intervention
Stents
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Atrial fibrillation (AF) and coronary artery disease (CAD) sometimes coexist in clinical practice, and the prevalence of CAD in AF patients and AF in percutaneous coronary artery intervention (PCI) patients has been reported to be around 8%–15% in Japan. According to the AHA expert consensus (A North American Perspective 2018), a DOAC plus DAPT plus DAPT should be terminated 1 month after PCI. Despite those unresolved issues, this meta‐analysis and four clinical trials on DOACs used in PCI patients will advance the future guidelines regarding the efficacy of a dual therapy with different types of DOACs in AF patients with CAD and may give cardiologists confidence in dual therapies during the early phase after PCI.
ISSN:1880-4276
1883-2148
DOI:10.1002/joa3.12317